Skip to main navigation Skip to search Skip to main content

Combating Sale of Counterfeit and Falsified Medicines Online: A Losing Battle

Kah Seng Lee, Siew Mei Yee, Syed Tabish Razi Zaidi, Rahul P Patel, Quan Yang, Yaser Mohammed Al-Worafi, Long Chiau Ming

Research output: Contribution to journalLetter

111 Citations (Scopus)

Abstract

The rapid growth of technology has transformed many brick-and-mortar businesses into online businesses, and medicines are now being sold over the internet. Influenced by the notions that online purchases are economical and do not require a prescription, the general public are keen to purchase medicine online through websites, social media and mobile apps. Online medicine purchase is presumed to be convenient and confidential, free from embarrassment of sharing personal and sensitive health information to a healthcare professional. Public in United States, Europe, Australia is generally aware that internet sales form part of the official medicines distribution channels, often a valid prescription is required for controlled medicine. However, unlicensed, substandard and falsified medicines with various dubious medical claims are advertised and sold illegally in many rogue online pharmacies (Jack, 2016). These include medications for weight loss, hair growth, and treatment of erectile dysfunction. Such medicines are termed as substandard, spurious, falsely labeled, falsified and counterfeit medical products by the World Health Organisation (WHO). Similarly, the European Commission defines such products as falsified medicines or fake medicines that pass themselves off as real, authorized medicines (European Commission, 2016). These medicines may contain substandard active ingredients, which are low quality and/or an incorrect amount, either too high or too low, and have not been properly evaluated by authorities in terms of quality, safety, and efficacy. It must be noted that falsified medicines are often confused with counterfeit medicines. According to European Commission, counterfeit medicines refers to medicines that do not comply with European Union law on intellectual and industrial property rights, for example, unregistered medicines sourced from parallel import (European Medicines Agency1). In this article, the illegal sales of both counterfeit and falsified medicines (CFMs) are discussed.

Original languageEnglish
Article number268
Pages (from-to)1-4
JournalFrontiers in Pharmacology
Volume8
DOIs
Publication statusPublished - 16 May 2017

Fingerprint

Dive into the research topics of 'Combating Sale of Counterfeit and Falsified Medicines Online: A Losing Battle'. Together they form a unique fingerprint.

Cite this